Bioventix Plc

Bioventix Plc

24.00
EUR
-0.40
(-1.64%)
103.49MMarket Cap
Mar 29Next Earn

Total Valuation

EUR

As of December 31, 2025, Bioventix Plc carries a market capitalization of 103.49M, placing it among publicly traded companies globally. Its enterprise value stands at 97.41M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap103.49M
Enterprise Value97.41M

Important Dates

Bioventix Plc's next confirmed earnings release is scheduled for March 29, 2027.

Earnings Date3/29/2027

Share Statistics

As of December 31, 2025, Bioventix Plc has 5.22M shares outstanding.

Shares Outstanding5.22M

Valuation Ratios

These figures are as of December 31, 2025.

PB Ratio8.17
P/TBV Ratio8.17

Financial Position

As of December 31, 2025, Bioventix Plc maintains a current ratio of 6.12, meaning it holds 6.1x the short-term assets needed to cover near-term liabilities.

Current Ratio6.12
Quick Ratio2.66

Financial Efficiency

These figures cover the twelve months ended December 31, 2025.

Employee Count13.00

Stock Price Statistics

EUR

As of the close on November 4, 2026, Bioventix Plc's stock has gained approximately 0.84% over the past 52 weeks. The 50-day moving average sits at 19.88, while the 200-day moving average is 18.62.

52-Week Price Change0.84%
50-Day Moving Average19.88
200-Day Moving Average18.62

Balance Sheet

EUR

These figures are as of December 31, 2025. Total book value stands at 12.66M, with working capital of 11.70M providing operational flexibility.

Cash & Cash Equivalents6.08M
Net Debt-6.08M
Equity (Book Value)12.66M
Book Value Per Share2.42
Working Capital11.70M